4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000105
President and CEO sold 50,000 shares at $31.40 ($1,570,000)
- President and CEO acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2023-06-16 | Option exercise | +50,000 | $0.68 | $34,000 | 2,289,913 | I: show line 1 in the form |
| Watts Ryan J. President and CEO | 2023-06-16 | Sale | −50,000 | $31.40 | $1,570,000 | 2,239,913 | I: show line 2 in the form |
| Open-market sales · 50,000 sh · avg $31.40 · $1,570,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2023-06-16 | Option exercise · Stock Option (right to buy) | −50,000 | 1,120,617 | D: show line 3 in the form |
Loading xslF345X04/wk-form4_1687300068.xml…